Kappac Pharma

Kappac_Pharma06 Jan 2015

Pharmaceuticals

₹

0.00 (0.00%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Kappac Pharma

Kappac Pharma

Pharmaceuticals

Kappac_Pharma06 Jan 2015

₹

0.00 (0.00%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
21-Nov-2023	BC	Trading Members of the Exchange are hereby informed that the undermentioned 73 companies that have remained suspended for more than 6 months would be delisted from the platform of the Exchange, with	23-Nov-2023
03-Jun-2021	BC	KAPPAC PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/06/2021 ,inter alia, to consider and approve Notice pursuant to regulation 29 of SEBI (	10-Jun-2021
01-Feb-2021	BC	KAPPAC PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2021 ,inter alia, to consider and approve unaudited financial results of the company	09-Feb-2021
04-Nov-2020	BC	KAPPAC PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2020 ,inter alia, to consider and approve Notice pursuant to regulation 29 of SEBI (	11-Nov-2020
26-Aug-2020	BC	KAPPAC PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/09/2020 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Lis	02-Sep-2020

No Rights has been declared by Kappac_Pharma

Book Closure

Record Date	Split Date	Purpose
23-Nov-2023	-	Trading Members of the Exchange are hereby informed that the undermentioned 73 companies that have remained suspended for more than 6 months would be delisted from the platform of the Exchange, with
10-Jun-2021	-	KAPPAC PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/06/2021 ,inter alia, to consider and approve Notice pursuant to regulation 29 of SEBI (
09-Feb-2021	-	KAPPAC PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2021 ,inter alia, to consider and approve unaudited financial results of the company
11-Nov-2020	-	KAPPAC PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2020 ,inter alia, to consider and approve Notice pursuant to regulation 29 of SEBI (
02-Sep-2020	-	KAPPAC PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/09/2020 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Lis

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Kappac Pharma Ltd ₹112.85(0.00/0.00%)	112.85	+0.00	341.48	-82.23	0.00	10.02
Astrazeneca Pharma India Ltd ₹5,424.45(+90.60/1.70%)	5,424.45	+90.60	13,561.13	71.45	85.02	20.71
Bliss GVS Pharma Ltd ₹119.10(-10.10/-7.82%)	119.10	-10.10	1,246.87	56.07	18.27	1.28
Cipla Ltd ₹1,424.75(+5.20/0.37%)	1,424.75	+5.20	115,033.60	54.70	34.98	4.44
Amrutanjan Health Care Ltd ₹775.50(-11.10/-1.41%)	775.50	-11.10	2,242.02	27.78	50.95	8.56
Abbott India Ltd ₹26,144.45(-459.90/-1.73%)	26,144.45	-459.90	55,556.96	15.92	48.50	17.87

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19
Gross Sales	0.00	0.00	0.00	0.00	0.00	0.00
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	0.00	0.00	0.00	0.00	0.00	0.00
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	-1.99	-0.19	0.00	0.00	0.00	0.00
Total Income	-1.99	-0.19	0.00	0.00	0.00	0.00
Total Expenditure	0.00	0.01	0.00	0.00	0.00	0.00
PBIDT	-1.99	-0.20	0.00	0.00	0.00	0.00
Interest	0.00	0.00	0.00	0.00	0.00	0.00
PBDT	-1.99	-0.20	0.00	0.00	0.00	0.00
Depreciation	0.00	0.00	0.00	0.00	0.00	0.00
Tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Reported Profit After Tax	-1.99	-0.20	0.00	0.00	0.00	0.00
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	-1.99	-0.20	0.00	0.00	0.00	0.00

EPS (Unit Curr.)	-0.66	-0.07	0.00	0.00	0.00	0.00
EPS (Adj) (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Calculated EPS (Unit Curr.)	-0.66	-0.07	0.00	0.00	0.00	0.00
Calculated EPS (Adj) (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Calculated EPS (Ann.) (Unit Curr.)	-2.63	-0.26	0.00	0.00	-0.01	0.00
Calculated EPS (Adj) (Ann.) (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	30.27	30.27	30.27	30.27	30.27	30.27
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	0.00	0.00	0.00	0.00	0.00	0.00
PBDTM(%)	0.00	0.00	0.00	0.00	0.00	0.00
PATM(%)	0.00	0.00	0.00	0.00	0.00	0.00

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 14	Mar 13	Mar 12	Mar 11	Mar 10	Mar 09
SOURCES OF FUNDS :
Share Capital	30.27	23.77	23.77	23.77	0.77	0.77
Reserves Total	7.84	0.13	0.21	0.28	0.20	-0.77
Equity Share Warrants	0.00	0.00	0.00	0.00	15.70	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	38.11	23.90	23.98	24.05	16.67	0.00
Secured Loans	0.00	0.00	0.00	0.00	0.00	0.00
Unsecured Loans	0.49	0.00	3.05	0.00	0.14	0.00
Total Debt	0.49	0.00	3.05	0.00	0.14	0.00
Total Liabilities	38.60	23.90	27.03	24.05	16.81	0.00
APPLICATION OF FUNDS :
Gross Block	0.00	0.00	0.00	0.00	0.00	0.00
Less : Accumulated Depreciation	0.00	0.00	0.00	0.00	0.00	0.00
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	0.00	0.00	0.00	0.00	0.00	0.00
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.00	0.00	0.00	0.00	0.00	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	19.50	19.50	14.07	11.05	4.44	0.50
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	0.00	0.00	0.00	0.00	0.00	0.00
Sundry Debtors	0.00	4.62	0.00	0.00	0.05	0.05
Cash and Bank	0.03	0.07	0.04	0.04	0.03	0.01
Loans and Advances	19.05	0.00	0.00	0.00	12.84	0.00
Total Current Assets	19.08	4.69	0.04	0.04	12.92	0.06
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	0.01	0.35	0.01	0.02	0.56	0.56
Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Total Current Liabilities	0.01	0.35	0.01	0.02	0.56	0.56
Net Current Assets	19.07	4.34	0.03	0.02	12.36	-0.50
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.01	0.00
Deferred Tax Assets	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Liability	0.00	0.00	0.00	0.00	0.00	0.00
Net Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Total Assets	38.57	23.84	14.10	11.07	16.81	0.00
Contingent Liabilities	0.00	0.00	0.00	0.00	0.00	0.00

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010
Cash and Cash Equivalents at Beginning of the year	0.07	0.03	0.04	0.04	0.01
Net Cash from Operating Activities	4.19	-4.36	-0.07	-0.67	-16.80
Net Cash Used In Investing Activities	0.00	-5.42	-3.02	-6.62	0.00
Net Cash Used In Financing Activities	0.52	9.82	3.09	7.29	16.82
Net Inc./Dec In Cash And Cash Equivalents	4.71	0.04	0.00	0.00	0.02
Cash And Cash Equivalents At End Of The Year	4.78	0.07	0.04	0.04	0.03

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

0.00%

FII Shareholding

0.00%

DII Shareholding

0.00%

Public Shareholding

100.00%

**Promoter pledged shareholding 0.00%

About Kappac Pharma Ltd

Kappac Pharma Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 341.48 crores. It has reported a sales of Rs. 0 crores and a net profit of Rs. -1.99 crores for the quarter ended December 2018. The company management includes , Rakesh Vekariya,Arun Vaghasiya,Ramjibhai Maganbhai Patel,Yunusbhai Satarbhai Syya (Kappac Pharma Ltd) among others.

Chairman

Registered office

303 Mahajben Arched Masjid,13/A Chakala Cross Lane,Mumbai,Maharashtra,400003

FAX :

Background

Incorporation Year1981

Face Value₹10

Market Lot1

How to buy Kappac Pharma shares on nse?

To buy Kappac Pharma shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Kappac Pharma share price today?

The Kappac Pharma shares price on nse is Rs.112.85 today.

What is the market cap of Kappac Pharma shares on BSE ?

The company has a market capitalization of Rs.341.48Cr

What is the PE & PB ratio of Kappac Pharma shares ?

PE is 0 and PB is 10.02

What is the 52 Week High and Low of Kappac Pharma shares?

Kappac Pharma stock price high: Rs.112.85 Kappac Pharma stock price low: Rs.0